The Pharmacy Times® COVID Treatment Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of patients infected with SARS-CoV-2.
March 27th 2023
Pharmacists on duty decline to dispense the medication to manage COVID-19, raising question about self-determination.
COVID-19 Infection in Children Associated with Post-COVID Conditions, Including Fatigue, WeaknessJuly 27th 2022
SARS-CoV-2 infection was associated with post-COVID-19 conditions for children, with associated risk factors including length of hospitalization, number of acute symptoms, and older age.
FDA Revises Paxlovid EUA to Allow State-Licensed Pharmacists to Prescribe Drug Under Certain ConditionsJuly 7th 2022
Paxlovid treats COVID-19 in adults and children [12 years of age and older weighing at least 88 pounds (40 kg)] with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death.
Study: Evusheld Offers Significant Prevention Against Severe COVID-19 Disease, DeathJune 23rd 2022
Analysis shows that individuals who received treatment within 3 days of symptom onset with tixagevimab and cilgavimab reduced their risk by 88% compared with the placebo.